cas 2573776-84-6|| where to buy methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

Nom du produit:methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

IUPAC Name:methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2573776-84-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2573776-84-6; Formule moléculaire:C13H15BrO2; Point de fusion:-; Code SMILES:O=C(OC)C1(C=2C=CC=C(Br)C2)CC(C)C1; Densité:

: Numéro de catalogue:CM1075490; Poids moléculaire:283.17; Point d'ébullition:; N° Mdl:; Stockage:

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: NX-1607; Nurix disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA. This is the first inhibitor of CBL-B to advance into clinical studies and a prime example of Nurix’s ability to target previously undruggable E3 ligases.